{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:57:52Z","timestamp":1759971472768,"version":"build-2065373602"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The HIV epidemic in Africa is still a serious public health concern, particularly for children who are more vulnerable to its negative consequences. Various studies carried out in different African nations have shown associations between these variables and increased mortality risk in children receiving antiretroviral therapy. However, the magnitude and consistency of these effects across different settings in Africa remain unclear, with a few studies reporting nonsignificant effects of advanced disease stage and immunological factors on mortality. This review is the first to provide a thorough analysis of the determinants of HIV-related mortality in children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This review followed the PRISMA guidelines, and relevant studies were obtained from the PubMed, CINAHL, EMBASE, and Google Scholar databases. Study selection, data extraction, and quality evaluation were carried out separately by two reviewers. A heterogeneity-based meta-analysis was conducted using random effect models. A sub group analysis was done based on age group and country.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 36 studies involving 198,957 study participants were included in the review. Advanced disease stage (WHO III\/IV) (HR 3.45; 95% CI 2.17\u20135.48), TB coinfection (HR 2.12; 95% CI 1.53\u20132.92), opportunistic infections (HR 2.04; 95% CI 1.59\u20132.62), immunosuppression (HR 2.50; 95% CI 2.01\u20133.11), and poor medication adherence (HR 3.36; 95% CI 2.10\u20135.38) and lack of cotrimoxazole use (HR 2.2; 95% CI 1.14\u20134.26) were significantly associated with a greater risk of HIV-related mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This review revealed key clinical, immunological, and treatment-related predictors of HIV-related mortality in children in Africa, including advanced disease stage, TB co-infection, immunosuppression, poor adherence, and lack of cotrimoxazole use. To reduce HIV-related child mortality in Africa, health policies should strengthen pediatric HIV care through context-specific service delivery. This includes early identification of advanced disease, management of opportunistic infections, access to cotrimoxazole prophylaxis, and age-appropriate adherence support, especially in under-resourced settings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12981-025-00784-y","type":"journal-article","created":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T12:20:50Z","timestamp":1759926050000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Determinants of HIV related mortality in African children on antiretroviral therapy: clinical and immunological insights from a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Sisay","family":"Moges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bereket Aberham","family":"Lajore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,8]]},"reference":[{"key":"784_CR1","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S2055-6640(20)30344-7","volume":"4","author":"LA Enane","year":"2018","unstructured":"Enane LA, et al. Traversing the cascade: urgent research priorities for implementing the \u2018treat all\u2019strategy for children and adolescents living with HIV in sub-Saharan Africa. J Virus Eradication. 2018;4:40\u20136.","journal-title":"J Virus Eradication"},{"key":"784_CR2","unstructured":"World health Organization(WHO). HIV\/AIDS WHO Africa Report. 2023 [cited 2024 April 22]; Available from: https:\/\/www.afro.who.int\/health-topics\/hivaids#:~:text=Treatment%20and%20care%20in%20children,died%20of%20AIDS%2Drelated%20illnesses"},{"issue":"10","key":"784_CR3","first-page":"e25617","volume":"23","author":"S Desmonde","year":"2020","unstructured":"Desmonde S, et al. Time-varying age\u2010and CD4\u2010stratified rates of mortality and WHO stage 3 and stage 4 events in children, adolescents and youth 0 to 24 years living with perinatally acquired HIV, before and after antiretroviral therapy initiation in the paediatric IeDEA global cohort consortium. Afr J Reprod Gynaecol Endoscopy. 2020;23(10):e25617.","journal-title":"Afr J Reprod Gynaecol Endoscopy"},{"issue":"suppl2","key":"784_CR4","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1093\/cid\/ciy013","volume":"66","author":"L Frigati","year":"2018","unstructured":"Frigati L, et al. Priorities for decreasing morbidity and mortality in children with advanced HIV disease. Clin Infect Dis. 2018;66(suppl2):S147\u201351.","journal-title":"Clin Infect Dis"},{"key":"784_CR5","unstructured":"World Health Organization. Global HIV Programme: Advanced HIV disease. 2022 [cited 2024 April 28]; Available from: https:\/\/www.who.int\/teams\/global-hiv-hepatitis-and-stis-programmes\/hiv\/treatment\/advanced-hiv-disease#:~:text=WHO%20defines%20advanced%20HIV%20disease,to%20have%20advanced%20HIV%20disease"},{"key":"784_CR6","unstructured":"World health Organization(WHO), Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy. 2017, WHO. p. 56."},{"issue":"2","key":"784_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4314\/star.v4i2.19","volume":"4","author":"D Edessa","year":"2015","unstructured":"Edessa D, Asefa F, Sheikahmed J. Early mortality among HIV-positive children initiated anti-retroviral therapy in Eastern ethiopia: a retrospective cohort study. Sci Technol Arts Res J. 2015;4(2):157\u201363.","journal-title":"Sci Technol Arts Res J"},{"issue":"2","key":"784_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/2325957413500852","volume":"14","author":"RS Mwiru","year":"2015","unstructured":"Mwiru RS, et al. Nutritional status and other baseline predictors of mortality among HIV-infected children initiating antiretroviral therapy in Tanzania. J Int Association Providers AIDS Care (JIAPAC). 2015;14(2):172\u20139.","journal-title":"J Int Association Providers AIDS Care (JIAPAC)"},{"key":"784_CR9","unstructured":"Nyandiko W et al. Predictors of mortality among children and adolescents living with HIV on antiretroviral therapy in Western Kenya. JAIDS J Acquir Immune Defic Syndr, 2022: pp. 10\u20131097."},{"issue":"1","key":"784_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-09418-6","volume":"20","author":"A Alebel","year":"2020","unstructured":"Alebel A, et al. Mortality rate among HIV-positive children on ART in Northwest ethiopia: a historical cohort study. BMC Public Health. 2020;20(1):1\u201311.","journal-title":"BMC Public Health"},{"key":"784_CR11","doi-asserted-by":"crossref","unstructured":"Ben-Farhat J, et al. Mortality and clinical outcomes in children treated with antiretroviral therapy in four African vertical programmes during the first decade of paediatric HIV care, 2001\u20132010. Volume 22. Tropical Medicine & International Health; 2017. pp. 340\u201350. 3.","DOI":"10.1111\/tmi.12830"},{"issue":"6","key":"784_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1097\/INF.0000000000000214","volume":"33","author":"M-A Davies","year":"2014","unstructured":"Davies M-A, et al. Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern africa: a collaborative analysis of treatment programs. Pediatr Infect Dis J. 2014;33(6):608\u201316.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"784_CR13","first-page":"235","volume":"25","author":"A Mulugeta","year":"2017","unstructured":"Mulugeta A, et al. Determinants of survival among HIV positive children on antiretroviral therapy in public hospitals, addis ababa, Ethiopia. Qual Prim Care. 2017;25(4):235\u201341.","journal-title":"Qual Prim Care"},{"key":"784_CR14","doi-asserted-by":"crossref","unstructured":"Sidamo N et al. Incidence and predictors of mortality among children on anti-retroviral therapy in public health facilities of Arba minch town, Gamo Gofa zone, Southern ethiopia; retrospective cohort study. Clin Mother Child Health, 2017. 14(3).","DOI":"10.4172\/2090-7214.1000267"},{"issue":"1","key":"784_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2431-10-33","volume":"10","author":"DC Wamalwa","year":"2010","unstructured":"Wamalwa DC, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in kenya: a prospective cohort. BMC Pediatr. 2010;10(1):33.","journal-title":"BMC Pediatr"},{"issue":"7","key":"784_CR16","doi-asserted-by":"publisher","first-page":"e22706","DOI":"10.1371\/journal.pone.0022706","volume":"6","author":"BC Zanoni","year":"2011","unstructured":"Zanoni BC, et al. Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa. PLoS ONE. 2011;6(7):e22706.","journal-title":"PLoS ONE"},{"issue":"1","key":"784_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12889-019-6482-1","volume":"19","author":"I Ahmed","year":"2019","unstructured":"Ahmed I, Lemma S. Mortality among pediatric patients on HIV treatment in sub-Saharan African countries: a systematic review and meta-analysis. BMC Public Health. 2019;19(1):149.","journal-title":"BMC Public Health"},{"key":"784_CR18","doi-asserted-by":"publisher","first-page":"105906","DOI":"10.1016\/j.ijsu.2021.105906","volume":"88","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906.","journal-title":"Int J Surg"},{"key":"784_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/1471-2458-13-154","volume":"13","author":"R Herzog","year":"2013","unstructured":"Herzog R, et al. Newcastle-Ottawa scale adapted for cross-sectional studies. BMC Public Health. 2013;13:154.","journal-title":"BMC Public Health"},{"issue":"1","key":"784_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40545-022-00448-6","volume":"15","author":"Y Biyazin","year":"2022","unstructured":"Biyazin Y, et al. Survival and predictors of mortality among HIV-positive children on antiretroviral therapy in public hospitals. J Pharm Policy Pract. 2022;15(1):48.","journal-title":"J Pharm Policy Pract"},{"key":"784_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2458-13-1047","volume":"13","author":"A Gebremedhin","year":"2013","unstructured":"Gebremedhin A, et al. Predictors of mortality among HIV infected children on anti-retroviral therapy in Mekelle hospital, Northern ethiopia: a retrospective cohort study. BMC Public Health. 2013;13:1\u20136.","journal-title":"BMC Public Health"},{"issue":"1","key":"784_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2431-12-161","volume":"12","author":"DN Koye","year":"2012","unstructured":"Koye DN, Ayele TA, Zeleke BM. Predictors of mortality among children on antiretroviral therapy at a referral hospital, Northwest ethiopia: a retrospective follow up study. BMC Pediatr. 2012;12(1):1\u20137.","journal-title":"BMC Pediatr"},{"key":"784_CR23","unstructured":"Tagesse N, Abebe W. Predictors of mortality in children and adolescents living with HIV on antiretroviral therapy, ethiopia: A retrospective cohort study. Ethiop J Pediatr Child Health, 2020. 15(2)."},{"issue":"1","key":"784_CR24","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1186\/s12887-022-03693-5","volume":"22","author":"GG Alemu","year":"2022","unstructured":"Alemu GG, et al. Survival time and predictors of death among HIV infected under five children after initiation of anti-retroviral therapy in West Amhara referral hospitals, Northwest Ethiopia. BMC Pediatr. 2022;22(1):670.","journal-title":"BMC Pediatr"},{"issue":"4","key":"784_CR25","first-page":"89","volume":"9","author":"S Bitew","year":"2017","unstructured":"Bitew S, Mekonen A, Assegid M. Predictors on mortality of human immunodeficiency virus infected children after initiation of antiretroviral treatment in Wolaita zone health facilities, ethiopia: retrospective cohort study. J AIDS HIV Res. 2017;9(4):89\u201397.","journal-title":"J AIDS HIV Res"},{"issue":"11","key":"784_CR26","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"1","key":"784_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101\u201329.","journal-title":"Biometrics"},{"issue":"4","key":"784_CR28","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s44197-024-00321-6","volume":"14","author":"S Moges","year":"2024","unstructured":"Moges S, et al. The impact of undernutrition and anemia on HIV-Related mortality among children on ART in Sub-Saharan africa: A systematic review and Meta-Analysis. J Epidemiol Global Health. 2024;14(4):1453\u201363.","journal-title":"J Epidemiol Global Health"},{"key":"784_CR29","unstructured":"Adem AK, Alem D, Girmatsion F. Factors affecting survival of HIV positive children taking antiretroviral therapy at Adama referral hospital and medical college, Ethiopia. J AIDS Clin Res, 2014. 5(3)."},{"key":"784_CR30","unstructured":"Belachew A. Predictors of Survival Time among Children On Antiretroviral Therapy In Dilchora Referral Hospital, Dire Dawa, East Ethiopia. 2019."},{"key":"784_CR31","doi-asserted-by":"publisher","first-page":"p20503121211069","DOI":"10.1177\/20503121211069477","volume":"10","author":"B Chekole","year":"2022","unstructured":"Chekole B, et al. Survival status and predictors of mortality among HIV-positive children initiated antiretroviral therapy in Bahir Dar town public health facilities Amhara region, ethiopia, 2020. SAGE Open Med. 2022;10:p20503121211069477.","journal-title":"SAGE Open Med"},{"issue":"6","key":"784_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/09540121.2014.997180","volume":"27","author":"G Ebissa","year":"2015","unstructured":"Ebissa G, Deyessa N, Biadgilign S. Predictors of early mortality in a cohort of HIV-infected children receiving high active antiretroviral treatment in public hospitals in Ethiopia. AIDS Care. 2015;27(6):723\u201330.","journal-title":"AIDS Care"},{"key":"784_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12887-021-03049-5","volume":"22","author":"BT Marie","year":"2022","unstructured":"Marie BT, Argaw WS, Bazezew BY. Time to death among HIV-infected under-five children after initiation of anti-retroviral therapy and its predictors in Oromiya Liyu zone, Amhara region, ethiopia: a retrospective cohort study. BMC Pediatr. 2022;22:1\u20139.","journal-title":"BMC Pediatr"},{"issue":"7","key":"784_CR34","doi-asserted-by":"publisher","first-page":"e0288475","DOI":"10.1371\/journal.pone.0288475","volume":"18","author":"E Mekonnen","year":"2023","unstructured":"Mekonnen E, et al. Time to death and its predictors among under-five children on antiretroviral treatment in public hospitals of addis ababa, addis ababa, ethiopia, a retrospective follow up study. PLoS ONE. 2023;18(7):e0288475.","journal-title":"PLoS ONE"},{"issue":"4","key":"784_CR35","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/tmi.12834","volume":"22","author":"Z Melaku","year":"2017","unstructured":"Melaku Z, et al. Outcomes among HIV-infected children initiating HIV care and antiretroviral treatment in Ethiopia. Tropical Med Int Health. 2017;22(4):474\u201384.","journal-title":"Tropical Med Int Health"},{"issue":"1","key":"784_CR36","first-page":"1046220","volume":"2022","author":"M Molla","year":"2022","unstructured":"Molla M, et al. Effects of undernutrition and predictors on the survival status of HIV-Positive children after started antiretroviral therapy (ART) in Northwest Ethiopia. Int J Pediatr. 2022;2022(1):1046220.","journal-title":"Int J Pediatr"},{"key":"784_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-019-1823-x","volume":"19","author":"A Oumer","year":"2019","unstructured":"Oumer A, Kubsa ME, Mekonnen BA. Malnutrition as predictor of survival from anti-retroviral treatment among children living with HIV\/AIDS in Southwest ethiopia: survival analysis. BMC Pediatr. 2019;19:1\u201310.","journal-title":"BMC Pediatr"},{"key":"784_CR38","doi-asserted-by":"publisher","first-page":"205031211983895","DOI":"10.1177\/2050312119838957","volume":"7","author":"G Arage","year":"2019","unstructured":"Arage G, et al. Survival rate of HIV-infected children after initiation of the antiretroviral therapy and its predictors in ethiopia: a facility-based retrospective cohort. SAGE Open Med. 2019;7:2050312119838957.","journal-title":"SAGE Open Med"},{"issue":"11","key":"784_CR39","doi-asserted-by":"publisher","first-page":"e0165772","DOI":"10.1371\/journal.pone.0165772","volume":"11","author":"JC Brophy","year":"2016","unstructured":"Brophy JC, et al. Survival outcomes in a pediatric antiretroviral treatment cohort in Southern Malawi. PLoS ONE. 2016;11(11):e0165772.","journal-title":"PLoS ONE"},{"issue":"8","key":"784_CR40","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1365-3156.2009.02315.x","volume":"14","author":"BC Fetzer","year":"2009","unstructured":"Fetzer BC, et al. Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in lilongwe, Malawi. Tropical Med Int Health. 2009;14(8):862\u20139.","journal-title":"Tropical Med Int Health"},{"key":"784_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3389\/fpubh.2020.00096","volume":"8","author":"T Munthali","year":"2020","unstructured":"Munthali T, et al. Survival of children living with HIV on Art in zambia: A 13-Years retrospective cohort analysis. Front Public Health. 2020;8:96.","journal-title":"Front Public Health"},{"key":"784_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-6444-7","volume":"19","author":"JN Mutanga","year":"2019","unstructured":"Mutanga JN, et al. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003\u20132015). BMC Public Health. 2019;19:1\u201312.","journal-title":"BMC Public Health"},{"issue":"6","key":"784_CR43","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/INF.0000000000001507","volume":"36","author":"EJ Abrams","year":"2017","unstructured":"Abrams EJ, et al. Despite access to antiretrovirals for prevention and treatment, high rates of mortality persist among HIV-infected infants and young children. Pediatr Infect Dis J. 2017;36(6):595\u2013601.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"784_CR44","doi-asserted-by":"publisher","first-page":"e591","DOI":"10.1542\/peds.2011-1187","volume":"130","author":"MM Kabue","year":"2012","unstructured":"Kabue MM, et al. Mortality and clinical outcomes in HIV-infected children on antiretroviral therapy in malawi, lesotho, and Swaziland. Pediatrics. 2012;130(3):e591\u20139.","journal-title":"Pediatrics"},{"issue":"11","key":"784_CR45","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1097\/INF.0000000000000457","volume":"33","author":"AF Auld","year":"2014","unstructured":"Auld AF, et al. Temporal trends in mortality and loss to follow-up among children enrolled in Cote d\u2019ivoire\u2019s National antiretroviral therapy program. Pediatr Infect Dis J. 2014;33(11):1134\u201340.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"784_CR46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.medmal.2016.07.003","volume":"47","author":"AEN Nlend","year":"2017","unstructured":"Nlend AEN, Loussikila AB. Predictors of mortality among HIV-infected children receiving highly active antiretroviral therapy. Med Et Maladies Infectieuses. 2017;47(1):32\u20137.","journal-title":"Med Et Maladies Infectieuses"},{"issue":"11","key":"784_CR47","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1097\/INF.0000000000000454","volume":"33","author":"J Nugent","year":"2014","unstructured":"Nugent J, et al. Predicting mortality in HIV-infected children initiating highly active antiretroviral therapy in a resource-deprived setting. Pediatr Infect Dis J. 2014;33(11):1148\u201355.","journal-title":"Pediatr Infect Dis J"},{"key":"784_CR48","doi-asserted-by":"crossref","unstructured":"Anigilaje EA, Aderibigbe SA. Mortality in a cohort of HIV-Infected children: A 12\u2010Month outcome of antiretroviral therapy in makurdi, Nigeria. Volume 2018. Advances in medicine; 2018. p. 6409134. 1.","DOI":"10.1155\/2018\/6409134"},{"key":"784_CR49","doi-asserted-by":"crossref","unstructured":"McHugh G et al. Clinical outcomes in children and adolescents initiating antiretroviral therapy in decentralized healthcare settings in Zimbabwe. Afr J Reprod Gynaecol Endoscopy, 2017. 20(1).","DOI":"10.7448\/IAS.20.1.21843"},{"issue":"4","key":"784_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.5897\/JAHR2018.0459","volume":"10","author":"AA Andargie","year":"2018","unstructured":"Andargie AA, Asmleash Y. Survival time of human immunodeficiency virus (HIV) infected children under 15 years of age after initiation of antiretroviral therapy in the university of Gondar comprehensive specialized hospital, Ethiopia. J AIDS HIV Res. 2018;10(4):49\u201355.","journal-title":"J AIDS HIV Res"},{"issue":"7","key":"784_CR51","doi-asserted-by":"publisher","first-page":"e27961","DOI":"10.1016\/j.heliyon.2024.e27961","volume":"10","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Long-term effect of antiretroviral therapy on mortality among HIV-positive children and adolescents in China. Heliyon. 2024;10(7):e27961.","journal-title":"Heliyon"},{"issue":"1","key":"784_CR52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s12879-024-09366-1","volume":"24","author":"BZ Woldegeorgis","year":"2024","unstructured":"Woldegeorgis BZ, et al. Mortality and its predictors among human immunodeficiency virus-infected children younger than 15 years receiving antiretroviral therapy in ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2024;24(1):471.","journal-title":"BMC Infect Dis"},{"key":"784_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41182-020-00212-z","volume":"48","author":"EW Mollel","year":"2020","unstructured":"Mollel EW, et al. Effect of tuberculosis infection on mortality of HIV-infected patients in Northern Tanzania. Trop Med Health. 2020;48:1\u201310.","journal-title":"Trop Med Health"},{"issue":"9","key":"784_CR54","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1177\/0956462421992257","volume":"32","author":"Y Hamada","year":"2021","unstructured":"Hamada Y, et al. HIV-associated tuberculosis. Int J STD AIDS. 2021;32(9):780\u201390.","journal-title":"Int J STD AIDS"},{"issue":"6","key":"784_CR55","doi-asserted-by":"publisher","first-page":"e929","DOI":"10.1016\/S2214-109X(24)00091-3","volume":"12","author":"A Kay","year":"2024","unstructured":"Kay A, et al. Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan africa: a retrospective observational cohort study. Lancet Global Health. 2024;12(6):e929\u201337.","journal-title":"Lancet Global Health"},{"issue":"4","key":"784_CR56","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1542\/pir.2018-0093","volume":"40","author":"PJ Holmberg","year":"2019","unstructured":"Holmberg PJ, Temesgen Z, Banerjee R. Tuberculosis in children. Pediatr Rev. 2019;40(4):168\u201378.","journal-title":"Pediatr Rev"},{"key":"784_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-019-7614-3","volume":"19","author":"S Lakoh","year":"2019","unstructured":"Lakoh S, et al. Causes of hospitalization and predictors of HIV-associated mortality at the main referral hospital in Sierra leone: a prospective study. BMC Public Health. 2019;19:1\u20139.","journal-title":"BMC Public Health"},{"key":"784_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3844-3","volume":"19","author":"TD Mangal","year":"2019","unstructured":"Mangal TD, et al. Determinants of survival of people living with HIV\/AIDS on antiretroviral therapy in Brazil 2006\u20132015. BMC Infect Dis. 2019;19:1\u20139.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"784_CR59","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/QAI.0b013e318207a55b","volume":"56","author":"P Lumbiganon","year":"2011","unstructured":"Lumbiganon P, et al. Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr. 2011;56(4):365\u201371.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"784_CR60","doi-asserted-by":"publisher","first-page":"e1002491","DOI":"10.1371\/journal.pmed.1002491","volume":"15","author":"A Judd","year":"2018","unstructured":"Judd A, et al. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and thailand: A cohort study. PLoS Med. 2018;15(1):e1002491.","journal-title":"PLoS Med"},{"issue":"3","key":"784_CR61","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/cid\/ciz253","volume":"70","author":"P The European","year":"2020","unstructured":"The European P, H.I.V.C.C.S.G.i E, Paediatric. Prevalence and clinical outcomes of poor immune response despite virologically suppressive antiretroviral therapy among children and adolescents with human immunodeficiency virus in Europe and thailand: cohort study. Clin Infect Dis. 2020;70(3):404\u201315.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"784_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4102\/sajhivmed.v20i1.1002","volume":"20","author":"BE van Wyk","year":"2019","unstructured":"van Wyk BE, Davids L-AC. Challenges to HIV treatment adherence amongst adolescents in a low socio-economic setting in cape town. South Afr J HIV Med. 2019;20(1):1\u20137.","journal-title":"South Afr J HIV Med"},{"issue":"12","key":"784_CR63","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.3201\/eid2612.202245","volume":"26","author":"AM Mandalakas","year":"2020","unstructured":"Mandalakas AM, et al. Tuberculosis among children and adolescents at HIV treatment centers in Sub-Saharan Africa. Emerg Infect Dis. 2020;26(12):2933\u201343.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"784_CR64","doi-asserted-by":"publisher","first-page":"e1004334","DOI":"10.1371\/journal.pmed.1004334","volume":"21","author":"S Mathur","year":"2024","unstructured":"Mathur S, et al. Estimating the impact of alternative programmatic Cotrimoxazole strategies on mortality among children born to mothers with HIV: A modelling study. PLoS Med. 2024;21(2):e1004334.","journal-title":"PLoS Med"},{"issue":"5","key":"784_CR65","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/jpids\/piy087","volume":"8","author":"DC Boettiger","year":"2019","unstructured":"Boettiger DC, et al. Temporal trends in co-trimoxazole use among children on antiretroviral therapy and the impact of co-trimoxazole on mortality rates in children without severe immunodeficiency. J Pediatr Infect Dis Soc. 2019;8(5):450\u201360.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"9448","key":"784_CR66","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1016\/S0140-6736(04)17442-4","volume":"364","author":"C Chintu","year":"2004","unstructured":"Chintu C, et al. Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial. Lancet. 2004;364(9448):1865\u201371.","journal-title":"Lancet"},{"issue":"9349","key":"784_CR67","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/S0140-6736(02)11921-0","volume":"360","author":"SM Graham","year":"2002","unstructured":"Graham SM. Prophylaxis against Pneumocystis carinii pneumonia for HIV-exposed infants in Africa. Lancet. 2002;360(9349):1966\u20138.","journal-title":"Lancet"},{"issue":"8","key":"784_CR68","first-page":"646","volume":"34","author":"JH Zhu","year":"2021","unstructured":"Zhu JH, et al. Effects of Cotrimoxazole prophylaxis initiation and discontinuation on mortality and attrition rates among HIV patients who initiate ART in Southwest china: an observational cohort study. Biomed Environ Sci. 2021;34(8):646\u20139.","journal-title":"Biomed Environ Sci"},{"key":"784_CR69","doi-asserted-by":"publisher","first-page":"1025944","DOI":"10.3389\/fcimb.2022.1025944","volume":"12","author":"CM Kifude","year":"2022","unstructured":"Kifude CM, et al. Initiation of anti-retroviral\/Trimethoprim-Sulfamethoxazole therapy in a longitudinal cohort of HIV-1 positive individuals in Western Kenya rapidly decreases asymptomatic malarial parasitemia. Front Cell Infect Microbiol. 2022;12:1025944.","journal-title":"Front Cell Infect Microbiol"}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00784-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-025-00784-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-025-00784-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T14:04:13Z","timestamp":1759932253000},"score":1,"resource":{"primary":{"URL":"https:\/\/aidsrestherapy.biomedcentral.com\/articles\/10.1186\/s12981-025-00784-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,8]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["784"],"URL":"https:\/\/doi.org\/10.1186\/s12981-025-00784-y","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,8]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This section is not applicable because it was conducted using secondary data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"102"}}